SB 613 revises Texas veterinary practice law to strengthen restrictions on corporate and private-equity involvement in veterinary medicine. The bill expands definitions used in Chapter 801 of the Occupations Code, including “affiliate” and “business entity,” and clarifies that a business entity is treated as a non-veterinarian unless all owners, partners, or shareholders are licensed veterinarians. It also broadens the statutory prohibition on outside control or exploitation of a veterinarian’s professional services, including arrangements that give a non-veterinarian controlling influence over clinical practice.
The bill specifically targets private equity firms and related entities by voiding contract provisions that bar veterinarians from competing, speaking critically about care quality or revenue-driven practices, or entering certain management arrangements with private equity-controlled entities. It also expands the list of permissible business support services that can be provided to veterinarians, such as accounting, marketing, legal, recruiting, insurance, and facility services, while preserving limits intended to prevent non-veterinarians from directing clinical judgment or practice operations. The bill further increases enforcement tools by raising the civil penalty for violations by unlicensed persons to $5,000 per day, authorizing attorney’s fees and court costs for prevailing prosecutors, and requiring the veterinary board to share evidence of criminal offenses with prosecutors.
In addition to the corporate-practice provisions, SB 613 updates disciplinary grounds and clarifies that entities can commit offenses under the chapter. It also makes explicit that business entities may not control compensation, fees, patient volume, time spent with patients, billing, records, referrals, or clinical communications, and may not interfere with a veterinarian’s professional judgment or selection of medical products and treatments. The bill applies prospectively to contracts entered into or renewed, and to conduct occurring on or after September 1, 2025.
The overall sentiment reflected by the bill’s structure is protective of veterinary professional independence and skeptical of outside ownership or management influence, especially from private equity. Because there were no committee transcripts or recorded votes provided, there is no direct evidence of debate, but the bill’s detailed restrictions suggest a policy concern about corporate control, revenue pressure, and interference with animal care decisions. The main point of contention likely centers on balancing veterinarian autonomy and consumer/animal welfare against the ability of business entities to provide management, financing, and support services in veterinary practices.
SB 613 would substantially amend Chapter 801 of the Occupations Code by tightening the corporate-practice rules for veterinary medicine, expanding prohibited conduct by business entities, and increasing civil penalties for violations. It would also create new statutory limits on private equity-related contracts, void certain noncompete and nondisparagement clauses, and authorize stronger enforcement and prosecutorial recovery of fees and costs. Veterinarians, veterinary clinics, business entities, private equity firms, and management-service organizations would be the primary affected parties.
The bill appears generally supportive of veterinarians’ professional independence and protective of clinical decision-making, with an evident concern about outside corporate or private-equity influence. No committee testimony or votes were provided, so there is no direct record of support or opposition in the materials, but the bill’s design indicates a reform-minded, regulatory approach rather than a compromise measure.
The likely central controversy is whether the bill goes too far in restricting private equity firms and other business entities from participating in veterinary practice operations. Supporters would likely favor the bill’s limits on non-veterinarian control, noncompete clauses, and revenue-based management arrangements as protections against interference with care. Opponents or affected industry groups would likely object that the bill could limit financing, management flexibility, and common business arrangements, even while it preserves many support services. Another possible point of contention is the increased civil penalty and expanded enforcement authority, which could be viewed as strengthening compliance or as creating heavier regulatory exposure.